title: FDG Whole-Body PET/MRI in Oncology: a Systematic Review.
abstract: The recent advance in hybrid imaging techniques enables offering simultaneous positron emission tomography (PET)/magnetic resonance imaging (MRI) in various clinical fields.18F-fluorodeoxyglucose (FDG) PET has been widely used for diagnosis and evaluation of oncologic patients. The growing evidence from research and clinical experiences demonstrated that PET/MRI with FDG can provide comparable or superior diagnostic performance more than conventional radiological imaging such as computed tomography (CT), MRI or PET/CT in various cancers. Combined analysis using structural information and functional/molecular information of tumors can draw additional diagnostic information based on PET/MRI. Further studies including determination of the diagnostic efficacy, optimizing the examination protocol, and analysis of the hybrid imaging results is necessary for extending the FDG PET/MRI application in clinical oncology.
authors.affiliation: Department of Nuclear Medicine, Soonchunhyang University Hospital, Cheonan, South Korea.
authors.forename: Hyun Woo
authors.initials: HW
authors.lastname: Kwon
authors.affiliation: Rheinisch Westfälische Technische Hochschule Aachen University, Aachen, Germany.
authors.forename: Ann-Katharina
authors.initials: AK
authors.lastname: Becker
authors.affiliation: Department of Radiology, Seoul National University College of Medicine, Seoul, South Korea.
authors.forename: Jin Mo
authors.initials: JM
authors.lastname: Goo
authors.affiliation: Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehang-ro, Jongno-gu, Seoul, 03080 Republic of Korea.
authors.forename: Gi Jeong
authors.initials: GJ
authors.lastname: Cheon
keywords: FDG; Oncology; PET/MRI; Positron emission tomography/magnetic resonance imaging